GCM
NEO icon

Gambit Capital Management’s NeoGenomics NEO Stock Holding History

Gambit Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
+11,039
New +$107K 0.09% 102

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Gambit Capital Management's NEO Position: Q2 2026 in Review

Gambit Capital Management opened a new position in NeoGenomics (NEO) in Q2 2026: 11,039 shares worth $161K. The stake represents 0.09% of the portfolio and ranks #102 among its holdings.

266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Gambit Capital Management held 11,039 shares of NeoGenomics worth $161K as of Q2 2026.
  • NeoGenomics was a new Gambit Capital Management position in Q2 2026.
  • NeoGenomics made up 0.09% of Gambit Capital Management's portfolio in Q2 2026, its #102 holding.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Gambit Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.